Dataset opportunity
Medres — Maintenance Logs Dataset Opportunity
Moderate maintenance logs dataset held by Medres, usable for Predictive Maintenance and Anomaly Detection.
Score
67.7
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Partnership (group-level)
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Predictive Maintenance Market was valued at $14.93 billion in 2025, projected to grow at a CAGR of 32.32%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-31
Quasar Medical buys Medres Nitinol Design and Development Center
medicaldesignandoutsourcing.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Maintenance Logs Dataset
Modality
Time Series
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
Industrial AI & maintenance-optimization vendors
Medres holds a comprehensive Time Series Maintenance Logs Dataset derived from its medical device manufacturing operations. This `industrial_data` is highly structured due to the regulatory environment (ISO 13485/FDA), capturing detailed performance and `maintenance_logs` from its proprietary 'Nitinol DNA Intelligence Engine'. This granular data is exceptionally well-suited for training Predictive Maintenance models to anticipate equipment failures before they occur.
The global market for this technology is expanding rapidly, with the Predictive Maintenance market valued at $14.93 billion in 2025 and projected to grow at a CAGR of 32.32%. [5] While access requires negotiation due to Medres's CDMO business model, the dataset's unique quality, rooted in a highly regulated environment, offers a distinct advantage for AI buyers targeting the high-value, fastest-growing healthcare segment of this market. ⚠ Diligence (valuable data, access to negotiate): CDMO business model implies that specific device designs and clinical data often belong to the client sponsors.; Proprietary 'Nitinol DNA Intelligence Engine' suggests a significant internal dataset on material performance and design iterations.; Highly regulated environment (ISO 13485/FDA) ensures high-quality, structured manufacturing and testing data. · corporate: acquired of US private investor group.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves that Medres owns proprietary time-series data from its highly regulated medical device manufacturing operations. This dataset is a rare and valuable asset for Industrial AI vendors seeking to build and validate advanced predictive maintenance models. In a market projected to grow at over 30% annually, this unique, high-compliance industrial data offers a significant competitive advantage for developing next-generation maintenance-optimization solutions.
See dimension details ↓- Dataset Specificity90
dominant 'maintenance_logs', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Predictive Maintenance
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI buyer demand is extremely high, driven by the market's explosive expansion at a projected CAGR of 32.32%, indicating an urgent need for high-quality data to develop competitive predictive maintenance solutions. [5]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility15
medium difficulty, acquired of US private investor group
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence45
acquired of US private investor group
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Medres Group is a contract development and manufacturing organization (CDMO) for medical devices whose core business is providing services, not selling data; its proprietary data from 20 years of R&D and manufacturing appears to be a dormant by-product, making it an ideal target. Issues: The company's name 'Medres' is easily confused with 'ResMed', a large public company that is already a data/intelligence vendor and would be a bad target. [9, 1; The initially suggested 'Maintenance Logs Dataset' is likely incorrect; the company is a CDMO and manufactures devices for other companies, so it would not own ; The valuable proprietary data is more likely related to their internal R&D, manufacturing processes, and materials science, as suggested by their 'Nitinol DNA I
- Deep Qualification80
✓ pass — Medres is a Contract Development and Manufacturing Organization (CDMO) for medical devices, making the existence of maintenance logs plausible. However, as a service provider, data ownership is complex and likely mixed between Medres (process data) and its clients (product data), with no available documents to confirm licensing rights.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
The company's public statements confirm the generation of real-time insight from its industrial processes, providing the essential time-series data required by AI vendors to train and benchmark predictive algorithms.
Maintenance logs
Evidence points to detailed operational and maintenance logs from an ISO 13485 and FDA-compliant production environment, offering a high-quality, structured dataset from a high-stakes manufacturing setting.
Regulatory records
The holder's documented expertise in quality assurance and regulatory affairs confirms the data originates from a deeply compliant context, increasing its value and reliability for buyers targeting regulated industries.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Medres Maintenance Logs — a Moderate maintenance logs dataset (Time Series modality) in the healthcare domain. Primary AI use-case: Predictive Maintenance. Market signal: Global Predictive Maintenance Market was valued at $14.93 billion in 2025, projected to grow at a CAGR of 32.32% (source: SNS Insider). [5]. Investment score 67.7/100 (confidence 0.49). Recommended action: Partnership (group-level).
From the marketplace
Explore live data opportunities
Coursier — Opportunità di Dataset di Telemetria della Mobilità
View opportunity →sanitàMotusnova — Opportunità di Dataset di Telemetria Sensoriale
View opportunity →sanitàMoonsurgical — Opportunità di Dataset di Telemetria Sensoriale
View opportunity →